Drug Information

Drug General Information
Drug ID
D07YXP
Former ID
DNC014325
Drug Name
9-[5-(beta-Carboline-9-yl)pentyl]-beta-carboline
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530824]
Structure
Download
2D MOL

3D MOL
Formula
C27H24N4
Canonical SMILES
C1=CC=C2C(=C1)C3=C(N2CCCCCN4C5=CC=CC=C5C6=C4C=NC=C6)C=N<br />C=C3
InChI
1S/C27H24N4/c1(6-16-30-24-10-4-2-8-20(24)22-12-14-28-18-26(22)30)7-17-31-25-11-5-3-9-21(25)23-13-15-29-19-27(23)31/h2-5,8-15,18-19H,1,6-7,16-17H2
InChIKey
MRZCXQWEBCLSNO-UHFFFAOYSA-N
PubChem Compound ID
46223112
Target and Pathway
Target(s) Cholinesterase Target Info Inhibitor [530824]
PANTHER Pathway Muscarinic acetylcholine receptor 1 and 3 signaling pathway
Muscarinic acetylcholine receptor 2 and 4 signaling pathway
Nicotinic acetylcholine receptor signaling pathway
WikiPathways Irinotecan Pathway
References
Ref 530824J Med Chem. 2010 May 13;53(9):3611-7.Bivalent beta-carbolines as potential multitarget anti-Alzheimer agents.
Ref 530824J Med Chem. 2010 May 13;53(9):3611-7.Bivalent beta-carbolines as potential multitarget anti-Alzheimer agents.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.